【レポートの概要（一部）】
1. Executive Summary
1.1 What Does This Report Cover?
1.1.1 The Human Tissue Banking Market – Our Definition
1.1.2 The Stem Cell Banking Market – Our Breakdown
1.2 Biobanking for Medicine: Technology, Industry and Market 2014-2024 Overview
1.3 Chapter Outlines
1.4 Speculative Aspects of Assessing the Biobanking Market
1.5 Research and Analysis Methods
1.6 Glossary of Terms in this Report
2. Introduction to Biobanking and its Applications
2.1 What is Biobanking?
2.2 Main Features of Biobanks
2.3 What Processes are Involved in Biobanking?
2.4 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.4.1 Volunteer Group: Population- vs. Disease-Based
2.4.2 Ownership Structure: Public vs. Private
2.5 The Guidelines and Standards for Biobanking
2.6 Laws and Regulations for Biobank-Based Research
2.6.1 HIPAA Amendments
2.7 Biobanking and the Pharmaceutical Industry
2.7.1 Biobanking in Research, Drug Discovery and Development
2.7.1.1 Understanding Disease Pathways
2.7.1.2 Drug Discovery
2.7.1.3 Biomarker Discovery in Drug Development
2.7.2 Biobanking for Therapeutics
2.7.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2014-2024
3.1 The World Biobanking for Medicine Market in 2013
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2018 and 2024
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2014-2024
3.4 Biobanks Stored Almost 1.3 Billion Specimens in 2013, and That Figure Increases
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2014-2024
3.6 Biobanking for Research: A $10bn Industry
3.6.1 Biobanking for Research: Revenue Forecast 2014-2024
3.6.2 Driving Forces Outweigh Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: A Worthwhile Endeavour or a Waste of Money?
3.7.1 Arguments Against Commercial Stem Cell Banking for Therapeutic Purposes
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2014-2024
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Use, 2014-2024
4. Biobanking for Research Purposes
4.1 Breakdown of the Biobanking for Research Market by Tissue Type, 2013
4.2 Biobanking for Research in 2018 and 2024: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2014-2024
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2013
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2014-2024
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2014-2024
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2014-2024
4.8 The Stem Cell Banking Market for Research in 2013
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2014-2024
4.9.1 A Shift in R&D Towards Stem Cells
4.10 Banking of Other Biologic Specimens for Research in 2013
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2014-2024
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2013: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2018 and 2024
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: A Grouped Revenue Forecast
5.4 How Many Stem Cell Samples Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2013
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2014-2024
5.7 The Adult Stem Cell Banking Market in 2013
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2014-2024
6. Leading National Markets 2014-2024
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Rapidly Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2013
6.3 The Leading National Markets: A Grouped Revenue Forecast 2014-2024
6.4 How Will Regional Market Shares Change to 2024?
6.5 The US Biobanking Market 2014-2024: Diversifying and Expanding
6.6 The Leading European Biobanking Markets 2014-2024: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: 215 Biobanks Were Licensed Under the HTA in 2013
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2014-2024: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share Between 2014 and 2024
6.8.1 The Chinese Biobanking Market 2014-2024: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2014-2024: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2014-2024: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2014-2024?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated with Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquotting: Patented Technology From CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: The Most Important Component of Biobanking?
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy- Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2013
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, ProCURE and PhaseZERO
8.2.3 Biopta Provides Fresh Human Tissues, for Which Demand is Growing
8.2.3.1 Services From Biopta: Fresh Tissue Sample Procurement and a Variety of Lab Services
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2014
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences
8.3.5 LifebankUSA: Placental and Cord Blood Banking Means a Significant Survival Advantage in Transplant Patients
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company, Accounting for 3% of the Private Stem Cell Banking Industry
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Facing Challenges due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 NeoStem Operates a Multi-Faceted Business Strategy
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Industry and Market 2014-2024
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2014
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.5 Biobanks are Fragmented and Uncoordinated
9.2.6 Lack of Standardisation is a Weakness of the Industry
9.2.7 Lack of Public Awareness Limits Number of Donors
9.2.8 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2014-2024
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2014-2024
10. Research Interviews from Our Survey
10.1 Interview with Dr Kirstin Goldring, Biobank and BioResource Coordinator, University College London, UK
10.1.1 On the Size of the UCL Biobank and How its Growing
10.1.2 On Users of UCL Biobank
10.1.3 On the Increasing Demand for Biobanked Samples
10.1.4 On Technology Used at UCL Biobank
10.1.5 On the Cost of Access to Samples
10.1.6 Concerns, Challenges and Restraining Factors
10.1.7 The Future of Biobanking
10.2 Interview With Dr Husein Salem, Chief Executive Officer, Precious Cells BioBank, London
10.2.1 On the Increasing Demand for Stem Cell Banking Services
10.2.2 On Novel Stem Cell Therapies in Development
10.2.3 Storage of Adult Stem Cells vs. Storage of Umbilical Cord Blood
10.2.4 On the Demand for Stem Cell Banking in Different Countries
10.2.5 On Challenges in the Industry
10.2.6 On Technology Used at Precious Cells
10.2.7 On Unmet Needs in the Stem Cell Banking Industry
10.2.8 On the Future of Stem Cell Banking
10.3 Interview with Dr David Bunton, CEO and Co-Founder, Biopta Ltd.
10.3.1 One the Use of Human Tissue Samples by Biopharmaceutical Companies
10.3.2 Human Tissue vs. Stem Cells
10.3.3 On the Technology Used in Biobanks
10.3.4 On the Future of the Biobanking Market
10.4 Interview with Dr Michael Leek, Commercial Operations Director, Pharmacells
10.4.1 On the Recent Increase in Stem Cell Banking Activity
10.4.2 On the Services of Pharmacells
10.4.3 On Adult Stem Cell Banking vs. Umbilical Cord Blood Banking
10.4.4 On Challenges Facing the Stem Cell Banking Market
10.4.5 On the Technology Used by Pharmacells
10.4.6 On the Future of the Market
10.5 Interview with Dr Tetsuro Wakatsuki, Chief Scientific Officer, InvivoSciences Inc.
10.5.1 On the Services Provided by InvivoSciences
10.5.2 On the Future of this Biobanking-Associated Market
11. Conclusions from the Research and Analysis
11.1 World Biobanking Market 2014-2024: High Revenue Growth Predicted
11.2 Biobanking for Research 2014-2024: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2014-2024: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples Means Increasing Revenue
11.5.2 Improving Biobanking Infrastructure Engenders Growth
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：医療用バイオバンキング市場（2014-2024）■ 英文：Biobanking for Medicine: Technology, Industry and Market 2014-2024
■ 発行日：2014年3月
■ 調査会社：visiongain
■ 商品コード：Visiongain-4052639
■ 調査対象地域：グローバル
- Occidental Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Occidental Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Occidental Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report …
- ベリリウムの世界市場：用途別（産業、民生機器、自動車用電子機器、防衛、テレコム、エネルギー、医療）、地域別予測Global Beryllium Market to reach USD 80.7 Million by 2025. Global Beryllium Market valued approximately USD 124.6 msillion in 2016 is anticipated to grow with a healthy growth rate of more than -4.71% over the forecast period 2017-2025. Key factors which give growth to the Beryllium market are increasing use of the metal and its alloys in key application industries including aerospace & defense, t …
- PVB中間膜の世界市場予測（～2024年）“Increasing use of PVB interlayers in automotive, building, and photovoltaic applications is expected to drive the market.” The PVB interlayers market size was estimated to be USD 3.1 billion in 2019 and is projected to reach USD 4.4 billion by 2024, at a CAGR of 7.3%. The market is driven by the growth of the end-use industries, such as automotive, building & construction, and photovoltaic, and r …
- 世界のウォータージェット切断加工機市場2015The Global Waterjet Cutting Machinery Industry Report 2015 is a professional and in-depth study on the current state of the Waterjet Cutting Machinery industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Waterjet Cutting Machinery market analysis is provided for the international markets including devel …
- 世界のアップストリーム開発動向：（石油・ガス開発）上位100アップストリーム資産Top 100 Global Upstream Developments Overview - Major Project Developments and Key Challenges Summary Upstream oil and gas assets play a major role in satisfying the world’s energy needs, and are located around the world in both onshore and offshore regions and in challenging conditions such as ultra-deep waters and freezing temperatures. Production is therefore technologically complex and necessi …
- がん治療用モノクローナル抗体（MAb）の世界市場2017-2021About Cancer Monoclonal AntibodiesThe mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics. Technavio’s analysts forecast the global …
- 膨脹式おもちゃの世界市場2017-2021ABSTRACTAbout Inflatable Toys The growth of inflatable toys directly depends on the amusement park market. The growth of the inflatable toys market looks promising as amusement parks need high maintenance and renewal of toys. Operators are concerned about the safety of individuals and the risks to the lives of people, which can result in the cancellation of their licenses. Therefore, continuous ma …
- 世界の腫瘍溶解性ウイルス治療パイプライン分析Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which coul …
- モノイソプロパノールアミンの世界市場2015Monoisopropanolamine (CAS 78-96-6) Market Research Report 2015 aims at providing comprehensive data on Monoisopropanolamine market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Monoisopropanolamine description, covers its application areas, manufacturing methods, patterns. It captures Monoisopropanolamine market trends, pays close attention to Monois …
- テキスタイルコーティング（織物被覆）の世界市場予測：PVC、PU、アクリル、SBR、天然ゴムThe textile coatings market is projected to reach USD 6.81 Billion by 2021, registering a CAGR of 3.5% between 2016 and 2021. The market will mostly be driven the growing end-use applications of textile coatings in industrial, construction, automotive, and protective clothing applications. Increasing quality standards in protective clothing sector and innovative technologies such as microencapsula …
- 気流管理の世界市場予測（～2023年）：ブランキングパネル、グロメット、コンテインメント、空気注入キットThe airflow management market is projected to grow from USD 475.2 Million in 2017 to reach USD 807.3 Million by 2023, at a CAGR of 9.24% between 2017 and 2023. Factors such as increasing number of data centers worldwide and improving cooling efficiency and thermal management in data centers are driving the growth of the airflow management market. The airflow management market has been segmented on …
- 股関節置換：企業と競争環境MediPoint: Total Hip Replacement - Current and Future Players Summary GlobalData has released its medical devices report, “MediPoint: Total Hip Replacement - Current and Future Players”. The report is an essential source of information and analysis on the global total hip replacement market. The mature market in the design of hip replacement products has led to a shift in the focus of developing o …
- バイオシミラー（バイオ後続品）の世界市場2016-2020About Biosimilars Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product. They have many similarities, but are not identical to, the …
- 世界の大静脈フィルター市場2015The Global Inferior Vena Cava Filters (IVCF) Industry Report 2015 is a professional and in-depth study on the current state of the Inferior Vena Cava Filters (IVCF) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Inferior Vena Cava Filters (IVCF) market analysis is provided for the international ma …
- 世界のクリプトスポリジウム検査市場The report presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cryptosporidium definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
